SCHEMBL5587455

SCHEMBL5587455

CCCCc1cc(O)c(O)c(C(=O)O)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.48
PPARA Q07869 3/20 0.45
PPARG P37231 2/20 0.45
PPARD Q03181 1/20 0.45
BID P55957 3/20 0.44
MCL1 Q07820 3/20 0.44
BCL2L1 Q07817 2/20 0.44
BAK1 Q16611 2/20 0.44
KAT8 Q9H7Z6 2/20 0.44
EP300 Q09472 1/20 0.44
KAT2A Q92830 1/20 0.44
KAT2B Q92831 1/20 0.44
KAT5 Q92993 1/20 0.44
SAE1 Q9UBE0 1/20 0.44
ALOX5 P09917 5/20 0.43
TOP2A P11388 1/20 0.43
PTPN1 P18031 2/20 0.42
PTPN11 Q06124 1/20 0.42
CNR2 P34972 1/20 0.41
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590550 0.96 PTGES (0.53) PTGESPPARAPPARGPPARDBID
SCHEMBL5590069 0.94 BID (0.52) PTGESPPARAPPARGPPARDBID
SCHEMBL5590509 0.94 BID (0.52) PTGESPPARAPPARGPPARDBID
SCHEMBL5590194 0.94 BID (0.52) PTGESPPARAPPARGPPARDBID
SCHEMBL5587994 0.94 BID (0.52) PTGESPPARAPPARGPPARDBID
SCHEMBL5586822 0.94 BID (0.52) PTGESPPARAPPARGPPARDBID
SCHEMBL5587709 0.91 PTPN1 (0.51) PTGESPPARAPPARGPPARDALOX5
SCHEMBL5590309 0.87 BID (0.43) PTGESPPARAPPARGPPARDBID
SCHEMBL5586775 0.86 PTGS2 (0.43) PTGESPTPN1PTPN11
SCHEMBL5589922 0.86 BID (0.46) PTGESPPARAPPARGPPARDBID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PTGES 1709/4885PPARA 2921/4885PPARG 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.